267
Views
7
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis and Antimicrobial Evaluation of Novel Triazole, Tetrazole, and Spiropyrimidine-Thiadiazole Derivatives

&
Pages 478-497 | Received 30 Oct 2018, Accepted 19 Mar 2019, Published online: 07 Apr 2019

References

  • A. A. Baeyer, “Systematik Und Nomenclatur Bicyclischer Kohlenwas- Serstoffe,” Berichte Der Deutschen Chemischen Gesellschaft 33, no. 3 (1900): 3771–5.
  • Y. Inubushi, and T. Ibuka, “Syntheses of 1-Azaspiro-[5.5]Undecanes: Stereoselective Syntheses of Perhydro- and Octahydrohistrioni- Cotoxin,”Heterocycles 17, no. 1 (1982): 507–36.
  • D. Kathirvelan, J. Haribabu, B. S. R. Reddy, C. Balachandran, and V. Duraipandiyan, “Facile and Diastereoselective Synthesis of 3,2′-Spiropyrrolidine-Oxindoles Derivatives, Their Molecular Docking and Antiproliferative Activities,” Bioorganic & Medicinal Chemistry Letters 25, no. 2 (2015): 389–99.
  • G. R. Martinez, P. A. Grieco, E. Williams, K. Kanai, and C. V. Srinivasan, “Stereocontrolled Total Synthesis of Antibiotic A23187 (Calcimycin),” Journal of the American Chemical Society 104, no. 5 (1982): 1436–8.
  • E. D. Ananiev, K. Ananieva, G. Abdulova, N. Christova, and E. Videnova, “Effects of Abamectin on Protein and RNA Synthesis in Primary Leaves of Cucurbita Pepo L. (Zucchini),” Bulgarian Journal of Plant Physiology 28, (2002): 85–91.
  • A. A. Mahmoud, A. A. Ahmed, T. Tanaka, and M. Iinuma, “Diterpenoid Acids from Grindelia Nana,” Journal of Natural Products 63, no. 3 (2000): 378–80.
  • T. C. McMorris, R. Chimmani, K. Alisala, M. D. Staake, G. Banda, and M. J. Kelner, “Structure-Activity Studies of Urea, Carbamate, and Sulfonamide Derivatives of Acylfulvene,” Journal of Medicinal Chemistry 53, no. 3 (2010): 1109–16.
  • B. Witkop, “Gelsemine,” Journal of the American Chemical Society 70, no. 4 (1948): 1424–7.
  • A. J. Poss, and R. K. Belter, “The Total Synthesis of Delesserine, Leucodrin, and Dilaspirolactone Aglycone,”Tetrahedron Letters 28, no. 23 (1987): 2555–8.
  • M. P. DeNinno, P. A. McCarthy, K. C. Duplantier, C. Eller, J. B. Etienne, M. P. Zawistoski, F. W. Bangerter, C. E. Chandler, L. A. Morehouse, E. D. Sugarman, et al. “Steroidal Glycoside Cholesterol Absorption Inhibitors,” Journal of Medicinal Chemistry 40, no. 16 (1997): 2547–54.
  • L. A. Porter, “Picrotoxinin and Related Substances,” Chemical Reviews 67, no. 4 (1967): 441–64.
  • S. Budavari, The Merck Index, 12th ed. (Whitehouse Station, NJ: Merck & Co, Inc., 2001), 68, 253, and 423.
  • R. Sarges, J. Bordner, B. W. Dominy, M. J. Peterson, and E. B. Whipple, “Synthesis, Absolute Configuration and Conformation of the Aldose Reductase Inhibitor Sorbinil,”Journal of Medicinal Chemistry 28, no. 11 (1985): 1716–20.
  • E. A. Laude, D. Bee, O. Crambes, and P. Howard, “Antitussive and Antibronchoconstriction Actions of Fenspiride in guinea-Pigs,” The European Respiratory Journal 8, no. 10 (1995): 1699–704.
  • C. J. Swain, R. Baker, C. Kneen, R. Herbert, J. Moseley, J. Saunders, E. M. Seward, G. I. Stevenson, M. Beer, and J. Stanton, “Novel 5-HT3 Antagonists: Indol-3-ylspiro(azabicycloalkane-3,5'(4'H)-oxazoles),” Journal of Medicinal Chemistry 35, no. 6 (1992): 1019–31.
  • M. Carmignani, A. R. Volpe, F. D. Monache, B. Botta, R. Espinal, S. C. D. Bonnevaux, C. D. Luca, M. Botta, F. Corelli, A. Tafi, et al. “Novel Hypotensive Agents from Verbesina Caracasana. 6. Synthesis and Pharmacology of Caracasandiamide,” Journal of Medicinal Chemistry 42, no. 16 (1999): 3116–25.
  • I. Inada, H. Satoh, N. Inatomi, H. Nagaya, and Y. Maki, “Spizofurone, a New anti-Ulcer Agent, Increases Alkaline Secretion in Isolated Bullfrog Duodenal Mucosa,”European Journal of Pharmacology 124, no. 1–2 (1986): 149–55.
  • J. R. Atack, “The Benzodiazepine Binding Site of GABA(A) Receptors as a Target for the Development of Novel Anxiolytics,” Expert Opinion on Investigational Drugs 14, no. 5 (2005): 601–18.
  • E. M. Smith, G. F. Swiss, B. R. Neustadt, P. McNamara, E. H. Gold, E. J. Sybertz, and T. Baum, “Angiotensin Converting Enzyme Inhibitors: spirapril and Related Compounds,” Journal of Medicinal Chemistry 32, no. 7 (1989): 1600–6.
  • A. S. Shawali, “1, 3, 4-Thiadiazoles of Pharmacological Interest: Recent Trends in Their Synthesis via Tandem 1, 3-Dipolar Cycloaddition: Review,” Journal of Advanced Research 5, no. 1 (2014): 1–17.
  • A. A. Abu-Hashem, H. A. R. Hussein, and K. M. Abu-Zied, “Synthesis of Novel 1, 2, 4-Triazolopyrimidines and Their Evaluation as Antimicrobial Agents,” Medicinal Chemistry Research 26, no. 1 (2017): 120–30.
  • A. B. Deyanov, R. Kh Niyazov, F. Ya Nazmetdinov, B. Y. Syropyatov, V. Kolla, and M. E. Konshin, “Synthesis and Biological Activity of Amides and Nitriles of 2-Arylamino-5-Carboxy (Carbethoxy)-6-Methylnicotinic Acids and 1-Aryl-6-Carbethoxy-7-Methyl-4-Oxo-1,4-Dihydropyrido[2,3-d]Pyrimidine,” Pharmaceutical Chemistry Journal 25, no. 4 (1991): 248–50.
  • R. Magan, C. Marin, J. M. Salas, M. B. Perez, and M. J. Rosales, “Cytotoxicity of Three New Triazolo-Pyrimidine Derivatives against the Plant Trypanosomatid: Phytomonas sp. isolated from Euphorbia characias,” Memórias Do Instituto Oswaldo Cruz 99, (2004): 651–6.
  • J. A. R. Navarro, J. M. Salas, M. A. Romero, Rosario Vilaplana, Francisco Gonzalez-Vílchez, and Rene Faure, “Cis-[PtCl2(4,7-H-5-Methyl-7-Oxo[1,2,4]Triazolo[1,5-a]Pyrimidine) 2]: A Sterically Restrictive New Cisplatin Analogue. Reaction Kinetics with Model Nucleobases, DNA Interaction Studies, Antitumor Activity, and Structure-Activity Relationships,” Journal of Medicinal Chemistry 41, no. 3 (1998): 332–8.
  • Y. Sato, Y. Shimoji, H. Fujita, H. Nishino, H. Mizuno, S. Kobayashi, and S. Kumakura, “Studies on Cardiovascular Agents. 6. Synthesis and Coronary Vasodilating and Antihypertensive Activities of 1, 2, 4-Triazolo [1, 5-a] Pyrimidines Fused to Heterocyclic Systems,” Journal of Medicinal Chemistry 23, no. 8 (1980): 927–37.
  • A. M. Dougherty, H. Guo, G. Westby, Y. Liu, E. Simsek, J. Guo, A. Mehta, P. Norton, B. Gu, T. Block, et al. “A Substituted Tetrahydro-Tetrazolo-Pyrimidine Is a Specific and Novel Inhibitor of Hepatitis B Virus Surface Antigen Secretion,”Antimicrobial Agents and Chemotherapy 51, no. 12 (2007): 4427–37.
  • M. M. A. El-Gendy, M. Shaaban, K. A. Shaaban, A. M. El-Bondkly, and H. Laatsch, “Essramycin: A First Triazolopyrimidine Antibiotic Isolated from Nature,” The Journal of Antibiotics 61, no. 3 (2008): 149–57.
  • A. A. Abu-Hashem, and A. S. Aly, “Chemistry of New Dimethyl-Benzo,-1, 3, 6-Oxadiazepine and 1, 3, 5-Triazepine Derivatives as Anticancer Agents,” Synthetic Communications 47, no. 24 (2017): 2417–25.
  • A. A. Abu-Hashem, and M. El-Shazly, “Synthesis of New Quinoxaline, Pyrimidine, and Pyrazole Furochromone Derivatives as Cytotoxic Agents,” Monatshefte Für Chemie - Chemical Monthly 148, no. 10 (2017): 1853–63.
  • A. A. Abu-Hashem, and M. El-Shazly, “Synthesis of New Isoxazole-, Pyridazine-, Pyrimidopyrazines and Their anti-Inflammatory and Analgesic Activity,”Medicinal Chemistry 14, no. 4 (2018): 356–71.
  • A. A. Abu-Hashem, “Synthesis and Biological Activity of Pyrimidines, Quinolines, Thiazines and Pyrazoles Bearing a Common Thieno Moiety,” Acta Poloniae Pharmaceutica 75 (2018): 59–70.
  • A. A. Abu-Hashem, and M. El-Shazly, “Synthesis, Reactions and Biological Activities of Furochromones: A Review,” European Journal of Medicinal Chemistry 90 (2015): 633–65.
  • (a) Abu-Hashem A. A., “Synthesis and Reaction of Novel Spiro-Pyrimidine Derivatives,” Journal of Heterocyclic Chemistry 51 (2014):1020–1026; (b) Elwan, N. M., Awad, E. M., Hassaneen, H. M., “Synthesis of 1,2,4-Triazolo[4,3-a]pyrimidine Derivatives by Cyclocondensation of a 2-Thioxopyrimidin-4(3H)-one with Hydrazonoyl Halides,” Helvetica Chimica Acta, 86 (2003):739–49.
  • (a) S. R. Jain, and A. Kar, “The Antibacterial Activity of Some Essential Oils and Their Combinations,” Planta Med 20, no. 04 (1971): 118–23; (b) K. J. Ryan, and C. G. Ray, Eds., Sherris Medical Microbiology, 4th ed. (New York, NY: McGraw-Hill, 2004).
  • P. Wolkoff, T. S. Nemeth, and S. M. Gibson, “Reaction of Hydrazonyl Halides with Derivatives of Thiourea and Thiosemicarbazide; a New Source of C-Amino- and C-Hydrazino-1,2,4-Triazoles,” Canadian Journal of Chemistry 53, no. 21 (1975): 3211–15.
  • A. F. Hegarty, M. Cashoman, J. B. Aylward, and F. L. Scott, “Ortho-Group Participation in Azocarbonium Ion and 1, 3-Dipolar Ion Formation,” Journal of the Chemical Society B: Physical Organic 57, (1971): 1879–83.
  • S. M. Riyadh, T. A. Farghaly, and S. M. Gomha, “Novel Polyazahetero- Cyclic Systems: Synthesis, Antitumor, and Antimicrobial Activities,” Archives of Pharmacal Research 33, no. 11 (2010): 1721–8.
  • T. E. Ali, and M. A. Ibrahim, “Synthesis and Antimicrobial Activity of Chromone-Linked 2-Pyridone Fused with 1, 2, 4-Triazoles, 1, 2, 4-Triazines and 1, 2, 4-Triazepines Ring Systems,” Journal of the Brazilian Chemical Society 21, no. 6 (2010): 1007–16.
  • A. A. Abu-Hashem, “Synthesis of New Furothiazolo Pyrimido Quinazolinones from Visnagenone or Khellinone,”Molecules 23, no. 11 (2018): 2793.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.